Katsuya Daimon

Title: Katsuya Daimon: Innovator in Biopharmaceutical Production

Introduction

Katsuya Daimon is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the production of enzymes and hormones. With a total of 2 patents to his name, Daimon's work has the potential to impact various medical applications.

Latest Patents

Daimon's latest patents include a method for producing aminopeptidase and a method for producing recombinant human FSH. The method for producing aminopeptidase involves transforming host bacteria with specific genes and culturing them to express both aminopeptidase and neutral protease. This efficient method allows for the collection of aminopeptidase from the culture mixture. The second patent focuses on producing recombinant human FSH in high yield and purity. This method includes several steps, such as culturing mammalian cells in a serum-free medium and employing various chromatography techniques to isolate active fractions of recombinant human FSH.

Career Highlights

Katsuya Daimon is currently associated with JCR Pharmaceuticals Co., Ltd., where he continues to innovate in the field of biopharmaceuticals. His work is characterized by a commitment to improving production methods that can lead to better therapeutic options.

Collaborations

Daimon has collaborated with notable colleagues, including Atsushi Sugimura and Hiroyuki Sonoda. These partnerships have likely contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Katsuya Daimon is a prominent figure in the biopharmaceutical industry, with innovative patents that enhance the production of essential biological compounds. His contributions are paving the way for advancements in medical treatments and therapies.